Skip to main content
YSB Inc. logo

YSB Inc. — Investor Relations & Filings

Ticker · 9885 LEI · 655600S0RFW1TQ6MZP78 HKEX Wholesale and retail trade
Open in API
Filings indexed 196 across all filing types
Latest filing 2024-11-26 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 9885

About YSB Inc.

http://www.ysbang.cn

YSB Inc. specializes in the development and operation of a digital pharmaceutical platform designed to connect various stakeholders within the healthcare supply chain outside of traditional hospital settings. The company's core activities involve the wholesale and retail distribution of pharmaceuticals and healthcare products. Key users of the platform include pharmaceutical manufacturers, distributors, vendors, pharmacies, and primary healthcare institutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Share Issue/Capital Change Classification · 1% confidence The document is a "Next Day Disclosure Return" (FF305) filed under Hong Kong Listing Rules 13.25A/17.27A, reporting a change in the company’s issued shares (31,678,555 new shares issued). It is not a general financing update or a call transcript etc., but a formal announcement of a new share issue/capital change. Therefore it falls under “Share Issue/Capital Change (SHA).”
2024-11-26 English
THE LATEST PROGRESS ON THE ACQUISITION OF THE TARGET COMPANY INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE
M&A Activity Classification · 1% confidence The document is a corporate announcement filed on the Hong Kong Stock Exchange regarding the latest progress on an acquisition, specifically the issue of consideration shares under the Company’s general mandate. It details the number of shares allotted and issued to various sellers as completion consideration for the acquisition of the target company. This clearly relates to M&A activity rather than a routine share issue for capital raising (which would be SHA) or a report publication announcement (RPA). Therefore, it falls under the category of M&A Activity (Code: TAR).
2024-11-26 English
GRANT OF SHARE AWARDS PURSUANT TO THE 2023 SHARE INCENTIVE PLAN
Regulatory Filings
2024-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
Regulatory Filings
2024-11-06 English
SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF THE TARGET COMPANY INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE
Regulatory Filings
2024-10-28 English
(I) DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF THE TARGET COMPANY INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE&#x3b; AND (II) CHANGE IN USE OF NET PROCEEDS FROM THE GL
Regulatory Filings
2024-10-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.